Schultz & Williams is thrilled to reengage with CMT Research Foundation as they work tirelessly to find treatments and cures for Charcot-Marie-Tooth disease. Their mission is to raise funds to invest in science that will lead to treatments and cures for CMT. Focused solely on this goal, CMT Research Foundation collaborates with researchers, biotech firms, and the pharmaceutical industry to expedite the development of therapies. Their efforts include advancing gene and cell therapies, supporting innovative research, and fostering a global community dedicated to improving the lives of those affected by CMT.
“The outstanding leadership at CMTRF is dedicated to finding a cure for CMT and they are utilizing best in class science to win their fight. The S&W team is honored to follow-up CMTRF’s successful EndGame campaign with an immediate second campaign to continue to seek an end to this disease.”
– Cathy Card Sterling, S&W Vice President
